Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that successive engagements of the same kind are coming in at progressively larger size. The question asks specifically about the unit size of repeatable business escalating. We need to look for management's own words describing a comparison against the company's own recent past, that it's already real and recurring, and that it's early. In the transcript, Eyal Harari discusses the business. He mentions that they have a strong pipeline, and they are expanding sales and marketing. He says: "we are going to be lowering our R&D expense to cover some of the growth in the sales and marketing." But that's about costs. He talks about 5G SA and that they are investing in sales and marketing to capture opportunities. He says: "we are going to increase our presence in Europe." But does he say that the deals themselves are getting larger? He mentions that they have multiyear contracts providing a strong backlog. But no explicit statement about the size of individual deals increasing. He mentions that they added Vodafone as a new customer, but that was through acquisition, and it's smaller. He says: "At the moment, it is a significant smaller." So not larger. He talks about the pipeline being healthy with a good mix of opportunities. But no mention of deal size escalation. He says: "we are confident in delivering fifth consecutive year of revenue growth" but that's about revenue growth, not necessarily unit size. He mentions that they are expanding sales and marketing to meet expected 5G standalone monitoring demand. But no specific statement about the size of contracts increasing. The question asks: "does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago?" I don't see any such statement. Management talks about growth, but not about the unit size escalating. They talk about more opportunities, more customers, but not that each new deal is larger. There is no mention of average deal size increasing, or that new customers start at higher levels, or that follow-on commitments are multiples, etc. Thus, the answer is NO. We need to be careful: the question says "Answer YES when management's own words convey...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.